Imiquimod is an immune response modifier commercially available as a 3.75 and 5% cream.
Topical imiquimod stimulates the innate and adaptive immune responses and induces …

Cutaneous warts are a common presenting complaint in children and adolescents.
Common, plantar, or flat warts are cutaneous manifestations of the human papillomavirus …

Toll-like receptors (TLRs) recognise highly conserved molecular structures, collectively
known as pathogen-associated molecular patterns. In the past two decades, development …

The prevalence of cutaneous viral warts in the general population is estimated to be 7-12%.
Many patients present to primary care with pain and discomfort along with other concerns …

Imiquimod 5% cream is approved for the topical treatment of external anogenital warts
caused by human papillomavirus (HPV) and for the skin cancer conditions superficial basal …

Topical imiquimod 5% cream (Aldara™) is an immune response modulator that is indicated
for the treatment of external anogenital warts, superficial basal cell carcinoma and actinic …

Purpose Bleomycin-coated microneedles were devised for delivery of bleomycin into the
sub-epidermal skin layer for the treatment of warts in order to provide patient convenience …

The evolutionary conserved Toll‐like receptors (TLRs) are the first identified and best
characterized pattern recognition receptors (PRRs) which discriminate self from nonself …

The monetary and personal costs to society of human papillomavirus (HPV) infection are
enormous. In order to make a comparison of different treatment methods we reviewed the …

Introduction Cutaneous warts are highly prevalent lesions caused by the infection of
keratinocytes by different types of human papillomaviruses. Although cutaneous warts are …